T-Cell Antigen Receptor Specificity
"T-Cell Antigen Receptor Specificity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The property of the T-CELL RECEPTOR which enables it to react with some antigens and not others. The specificity is derived from the structure of the receptor's variable region which has the ability to recognize certain antigens in conjunction with the MAJOR HISTOCOMPATIBILITY COMPLEX molecule.
| Descriptor ID |
D037182
|
| MeSH Number(s) |
G12.450.900
|
| Concept/Terms |
T-Cell Antigen Receptor Specificity- T-Cell Antigen Receptor Specificity
- T Cell Antigen Receptor Specificity
- T-Cell Receptor Specificity
- Specificity, T-Cell Receptor
- T Cell Receptor Specificity
T-Cell Specificity- T-Cell Specificity
- Specificity, T-Cell
- T Cell Specificity
- T-Cell Immunologic Specificity
- Immunologic Specificity, T-Cell
- Specificity, T-Cell Immunologic
- T Cell Immunologic Specificity
|
Below are MeSH descriptors whose meaning is more general than "T-Cell Antigen Receptor Specificity".
Below are MeSH descriptors whose meaning is more specific than "T-Cell Antigen Receptor Specificity".
This graph shows the total number of publications written about "T-Cell Antigen Receptor Specificity" by people in this website by year, and whether "T-Cell Antigen Receptor Specificity" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2008 | 0 | 2 | 2 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 1 | 2 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 2 | 3 |
| 2017 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2021 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "T-Cell Antigen Receptor Specificity" by people in Profiles.
-
Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant. Blood. 2021 05 13; 137(19):2585-2597.
-
Clonally Focused Public and Private T Cells in Resected Brain Tissue From Surgeries to Treat Children With Intractable Seizures. Front Immunol. 2021; 12:664344.
-
Infusion of cytotoxic T lymphocytes for the treatment of viral infections in hematopoetic stem cell transplant patients. Curr Opin Infect Dis. 2018 08; 31(4):292-300.
-
Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1. Mol Ther. 2017 09 06; 25(9):2202-2213.
-
Broadly-specific cytotoxic T cells targeting multiple HIV antigens are expanded from HIV+ patients: implications for immunotherapy. Mol Ther. 2015 Feb; 23(2):387-95.
-
Toward immunotherapy with redirected T cells in a large animal model: ex vivo activation, expansion, and genetic modification of canine T cells. J Immunother. 2014 Oct; 37(8):407-15.
-
Activating and propagating polyclonal gamma delta T cells with broad specificity for malignancies. Clin Cancer Res. 2014 Nov 15; 20(22):5708-19.
-
Complementation of antigen-presenting cells to generate T lymphocytes with broad target specificity. J Immunother. 2014 May; 37(4):193-203.
-
PD-1 and Tim-3 regulate the expansion of tumor antigen-specific CD8? T cells induced by melanoma vaccines. Cancer Res. 2014 Feb 15; 74(4):1045-55.
-
Enhanced responses to tumor immunization following total body irradiation are time-dependent. PLoS One. 2013; 8(12):e82496.